Table 2.
Baseline details of LN patients
| Patient ID | Sex | Age | Ethnicity | Biopsy result | Urine PCR (mg/mmol) | Serum albumin (g/L) | Treatment at time of biopsy* (mg) |
|---|---|---|---|---|---|---|---|
| LN1 | F | 49 | Asian | III | 58 | 38 | P20, H400 |
| LN2 | F | 34 | White | IV,V | 457 | 30 | P20, MP |
| LN3 | F | 20 | Black | V | 123 | 28 | P30, H400 |
| LN4 | F | 31 | White | IV | 533 | 21 | P10, H400, M1500 |
| LN5 | F | 30 | White | V | 569 | 23 | P10, H400 |
| LN6 | F | 35 | Black | III | 202 | 30 | P5, C |
| LN7 | F | 29 | Asian | III | 96 | 20 | P15, A100 |
| LN8 | F | 33 | Asian | III/V | 208 | 36 | P12.5, H200 |
| LN9 | F | 27 | Asian | III | 34 | 28 | P60, C |
| LN10 | F | 18 | Asian | IV | 66 | 44 | P10, M2000 |
| LN11 | M | 19 | Asian | IV | 1017 | 17 | P20, M1000, C |
| LN12 | F | 43 | White | II | 312 | 34 | H400 |
| LN13 | F | 48 | White | II | 127 | 33 | H400, MP |
| LN14 | F | 34 | White | V | 366 | 34 | P20, A100 |
| LN15 | F | 56 | White | III/V | 88 | 43 | P5, A100 |
| LN16 | F | 28 | Black | IV/V | 297 | 37 | P20 |
| LN17 | F | 21 | Asian | IV | 65 | 43 | P15, A 150 |
*In a number of cases, the treatment was changed as a result of the biopsy (eg, the addition of immunosuppressant drugs to high-dose corticosteroids) but those drugs are not included in the table as they would have no effect on samples taken before the drug was started, that is, at the time of the biopsy.
(M)P, (methyl)prednisolone; A, azathioprine; C, cyclophosphamide; H, hydroxychloroquine; LN, lupus nephritis; M, mycophenolate mofetil; PCR, protein creatinine ratio.